OXYTETRACYCLINE Drug Patent Profile
✉ Email this page to a colleague
When do Oxytetracycline patents expire, and when can generic versions of Oxytetracycline launch?
Oxytetracycline is a drug marketed by Hikma, Impax Labs, Proter, and Purepac Pharm. and is included in four NDAs.
The generic ingredient in OXYTETRACYCLINE is oxytetracycline hydrochloride. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXYTETRACYCLINE?
- What are the global sales for OXYTETRACYCLINE?
- What is Average Wholesale Price for OXYTETRACYCLINE?
Summary for OXYTETRACYCLINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| DailyMed Link: | OXYTETRACYCLINE at DailyMed |
Recent Clinical Trials for OXYTETRACYCLINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Oslo | N/A |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for OXYTETRACYCLINE
Anatomical Therapeutic Chemical (ATC) Classes for OXYTETRACYCLINE
US Patents and Regulatory Information for OXYTETRACYCLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | OXYTETRACYCLINE HYDROCHLORIDE | oxytetracycline hydrochloride | CAPSULE;ORAL | 060770-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Purepac Pharm | OXYTETRACYCLINE HYDROCHLORIDE | oxytetracycline hydrochloride | CAPSULE;ORAL | 060634-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Impax Labs | OXYTETRACYCLINE HYDROCHLORIDE | oxytetracycline hydrochloride | CAPSULE;ORAL | 060760-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Proter | OXYTETRACYCLINE HYDROCHLORIDE | oxytetracycline hydrochloride | CAPSULE;ORAL | 060869-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
